Preface of CHIVR, 2026

Curr HIV Res. 2026 Mar 30. doi: 10.2174/011570162X494580260310065901. Online ahead of print.

Abstract

This year marks the 24th anniversary of Current HIV Research (formerly Virus and Immune Disease Research). As we move into 2026, the global response to HIV/AIDS continues to evolve, driven by significant advances in understanding viral persistence, viral reservoirs, immune regulation, and therapeutic innovation. The field is increasingly focused on strategies aimed at achieving a cure or functional cure, reflecting a forward-looking research agenda. We are witnessing a paradigm shift - from viral suppression to viral eradication or sustained remission without therapy. The complexity of HIV latency, immune exhaustion, and host - virus interactions demands bold, interdisciplinary collaboration. In this evolving scientific era, Current HIV Research remains dedicated to serving as a premier platform for high-impact discoveries that integrate fundamental molecular insights with translational and clinical innovation.

Keywords: Current HIV Research; HIV latency; HIV research community; Immune Disease Research; preface; therapeutic innovation..